Early Career Atrial Fibrillation & Arrhythmia Award (ECA3)

[Previously the AF Research Award]


This important research award encourages clinical, health services and population health research in the field of atrial fibrillation, syncope and prevention of sudden cardiac death.

Four to six (4-6) awards totaling up to $600,000 (each individual award can be up to $150,000) will be awarded based on an independent peer review process. Funded research must be completed within 36 months from the start of funding.

To be eligible, applicants must:
•  Be a CCS and CANet member;
•  The Principle Investigator MUST be an Early Career Investigator, that is a researcher who has held a full time research appointment for a period of no longer than 7 years as of the competition deadline;
•  Hold an MD, and/or PhD and/or PharmD, or equivalent degree;
•  Be a Canadian citizen or landed immigrant with permanent residence in Canada;
•  Proposals that are part of a larger research project must clearly identify the portion of the project that would be funded in its entirety by this award;
•  Not have received funding from another organization (e.g., academic/ research institution, federal or provincial government funding agency, charity or NGO, pharmaceutical company, other research funder) for the proposal being submitted;
•  Not involve a drug and/or medical device supply from any industry company.


Note: The award funds clinical, health services/systems, and population health research (see CIHR definitions for Themes II-IV research). Proposals for basic biomedical (Theme I) research will not be considered.

ccs logo 
 logo canet cmyk


Bristol Myers Squibb Pfizer Logo transparent background